Board directors in Egetis Therapeutics acquire shares
June 16, 2023
Stockholm, Sweden, June 16, 2023. Egetis Therapeutics AB (publ) (STO: EGTX) (the “Company”) today announced that Board directors Gunilla Osswald and Elisabeth Svanberg have acquired shares in the Company. On June 15, 2023, Gunilla Osswald acquired 40,000 shares and on June 5, 2023, Elisabeth Svanberg acquired 10 280 shares. Gunilla Osswald’s total holding in the Company amounts to 40,000 shares and Elisabeth Svanberg’s s total holding in the Company now amounts to 37,676 shares.